Filter
527
Filtered Results: 527
Text search:
saudi
arabia
Featured
Recommendations
44
New Publications
101
Language
Document type
No document type
224
Studies & Reports
159
Guidelines
68
Strategic & Response Plan
19
Manuals
17
Situation Updates
14
Fact sheets
13
Resource Platforms
5
Training Material
4
Infographics
2
Brochures
1
Videos
1
Countries / Regions
Global
59
Yemen
39
Syria
26
Middle East and North Africa
22
Saudi Arabia
18
Germany
17
South Sudan
12
Somalia
10
Egypt
9
Ethiopia
9
Mali
9
South Africa
8
Sudan
8
Niger
7
Africa
7
Jordan
7
Lebanon
7
Brazil
7
Iraq
7
Kenya
6
India
6
Mozambique
5
Bangladesh
5
Russia
5
Djibouti
5
Chad
5
Myanmar / Burma
5
Pakistan
5
Nigeria
4
Afghanistan
4
Morocco
4
Asia
4
West and Central Africa
4
Tunisia
4
East and Southern Africa
4
Greece
4
Palestine
4
Libya
4
Nepal
3
China
3
Burkina Faso
3
Philippines
3
Cambodia
3
Venezuela
3
South–East Asia Region
3
Uganda
3
Angola
3
Indonesia
3
Thailand
2
Mexico
2
Turkey
2
Sierra Leone
2
Iran
2
Qatar
2
Mauritania
2
Italy
2
Guinea-Bissau
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
Western and Central Europe
2
Portugal
2
Vietnam
2
Ghana
1
Benin
1
Rwanda
1
Albania
1
Laos
1
Burundi
1
Peru
1
Malawi
1
Guinea
1
Armenia
1
Haiti
1
Eastern Europe and Central Asia
1
Paraguay
1
France
1
United Kingdom
1
Spain
1
Israel
1
Eastern Europe
1
Papua New Guinea
1
Georgia
1
Central African Republic
1
Honduras
1
Botswana
1
Liberia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
125
Clinical Guidelines
50
Public Health
45
Women & Child Health
30
Key Resources
15
Capacity Building
7
Pharmacy & Technologies
5
Toolboxes
COVID-19
87
Mental Health
52
Refugee
38
Conflict
29
AMR
21
HIV
20
Rapid Response
19
NTDs
19
Health Financing Toolbox
19
Planetary Health
18
NCDs
14
Global Health Education
14
TB
13
Disability
12
Pharmacy
9
Ebola
8
Caregiver
7
Polio
6
Zika
4
Specific Hazards
3
Cholera
3
Social Ethics
2
Natural Hazards
1
Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...
The HHFA Comprehensive guide serves as the main reference document for planning and implementing a country HHFA. This guide will promote understanding of:
What the HHFA is and the information it can and cannot provide.
The HHFA modules, questionnaires and CSPro electronic data collection tool.
Th...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode
worms) of the genus Schistosoma. At least 249 million people required preventive treatment in
2012. Preventive treatment, which should be repeated over a number of years, will reduce and
prevent morbidity.
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
The World health statistics report is the annual compilation of health and health-related indicators which has been published by the World Health Organization (WHO) since 2005. The 2023 edition reviews more than 50 health-related indicators from the Sustainable Development Goals (SDGs) and WHO’s T...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
